Topical Treatment of Human Skin and Cultured Keratinocytes with High-Dose Spironolactone Reduces XPB Expression and Induces Toxicity

by M. Alexandra Carpenter, Michael G. Kemp
Published 2021-09-01

Multiple ATR-Chk1 pathway proteins preferentially associate with checkpoint-inducing DNA substrates.

by Seçil Yilmaz, Aziz Sancar, Michael G Kemp
Published 2011-01-01

Pharmacological inhibition of cryptochrome and REV-ERB promotes DNA repair and cell cycle arrest in cisplatin-treated human cells

by Nadeen Anabtawi, William Cvammen, Michael G. Kemp
Published 2021-09-01

The Impact of the Circadian Clock on Skin Physiology and Cancer Development

by Janet E. Lubov, William Cvammen, Michael G. Kemp
Published 2021-06-01

Spironolactone and XPB: An Old Drug with a New Molecular Target

by Ryan D. Gabbard, Robert R. Hoopes, Michael G. Kemp
Published 2020-05-01

Impact of Age and Insulin-Like Growth Factor-1 on DNA Damage Responses in UV-Irradiated Human Skin

by Michael G. Kemp, Dan F Spandau, Jeffrey B. Travers
Published 2017-02-01